Front > Comment


Dror Marmor  illustration: Gil Gibli As housing demand slows, so does supply

Building starts in 2017 will be far less than Israel needs, despite the government's promises.

Shiri Habib-Valdhorn  illustration: Gil Gibli Teva: Right person, wrong time?

Kåre Schultz has turned a company round before, but the challenge at Teva is huge.

Norman Bailey  illustration: Gil Gibli What's to be done about Israel's woeful public diplomacy?

Israel needs to fight the war over perceptions with professional weapons.

Yoav Karny  illustration: Gil Gibli Ayelet Shaked's role reversal

Justice ministers should uphold the rule of law, but Shaked is undermining it and Israel's standing.

Eli Tsipori  illustration: Gil Gibli Kite Pharma was a $12b missed opportunity for Israel

Some Israeli media headlines depicted Kite as an Israeli exit. But it is a US company that does no business in Israel and has no employees here.

Dror Marmor  illustration: Gil Gibli Those slippery home price statistics

Three months ago we hailed "the steepest price fall since 2007". Now it turns out there was no such thing.

Norman Bailey  illustration: Gil Gibli Approaching the precipice

As war drums start to accompany a breakdown in civility in the West, investors should beware.

Twitter Facebook Linkedin RSS Newsletters גלובס MAD Conference 2017